BRIEF-Bristol Myers Squibb To Acquire Orbital Therapeutics-March 2024-www.financetom.com

BRIEF-Bristol Myers Squibb To Acquire Orbital Therapeutics

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Bristol Myers Squibb To Acquire Orbital Therapeutics

Oct 10, 2025 8:23 AM

Oct 10 (Reuters) - Bristol-Myers Squibb Co ( BMY ):

* BRISTOL MYERS SQUIBB STRENGTHENS AND DIVERSIFIES CELL

THERAPY

PORTFOLIO WITH ACQUISITION OF ORBITAL THERAPEUTICS

* BRISTOL-MYERS SQUIBB CO ( BMY ) - BMS TO PAY $1.5 BILLION IN CASH

FOR

ORBITAL

Source text:

Further company coverage:

Previous page： Takeda's HYQVIA Approved in Japan To Treat Immunodeficiency Next page： Loblaw Signs Automatic Share Purchase Plan

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Takeda's HYQVIA Approved in Japan To Treat Immunodeficiency

Dec 27, 2024

Takeda Pharmaceutical Company Limited ( TAK ) announced on Friday that the Japanese Ministry of Health, Labour and Welfare has approved HYQVIA (Immune Globulin Infusion 10% with Recombinant Human Hyaluronidase) for the treatment of patients with agammaglobulinemia or hypogammaglobulinemia. These conditions, characterized by low or absent antibody levels, result in an increased risk of serious infections. This approval introduces the...

Loblaw Signs Automatic Share Purchase Plan

Dec 27, 2024

07:57 AM EST, 12/27/2024 (MT Newswires) -- Loblaw Companies ( LBLCF ) on Friday said it signed an automatic share purchase plan (ASPP) with a broker to facilitate repurchases of its common shares under its normal course issue bid. Loblaw ( LBLCF ) may buy back up to 15.3 million shares in the bid, which terminates on May 5. ...

BioNTech enters settlement with US agency, UPenn over COVID vaccine royalties

Dec 27, 2024

(Reuters) - BioNTech has entered into two separate settlement agreements with the U.S. National Institutes of Health and the University of Pennyslvania over the payment of royalties related to its COVID-19 vaccine, the company said in filings on Friday. The German company, which partners with U.S. pharma giant Pfizer for its COVID-19 vaccine, said it would pay $791.5 million to...

Onex Buys Back 3.1% of Shares for $264.2 Million in Substantial Issuer Bid

Dec 27, 2024

07:55 AM EST, 12/27/2024 (MT Newswires) -- Onex ( ONEXF ) said Friday that it bought back 3.1% of its shares for $264.2 million in a substantial issuer bid that expired on Monday. The company repurchased for cancellation 2.3 million outstanding subordinate voting shares at $117.00 apiece. The bid had authorized the company to repurchase for cancellation up to $400...